
    
      A multi-center, open-label clinical pharmacology trial to investigate the PK, tolerability,
      and safety of brexpiprazole QW formulation administered as single and multiple doses.

      The trial comprises the single-dose period (Cohort 1) and the multiple-dose period (Cohort
      2). The dose used in the multiple-dose period (Cohort 2) will be determined based on plasma
      drug concentrations obtained in the single-dose period (Cohort 1).
    
  